AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Dose-Response Relationship, RadiationUltraviolet RaysNeoplasmsRadiation InjuriesRadiation DosageRadiation, IonizingCarcinogensRadiotherapyRadiation ToleranceRadiotherapy DosageAneuploidyCombined Modality TherapyCell Transformation, NeoplasticRadiationBreast NeoplasmsRadiation OncologyRadiation ProtectionRisk AssessmentRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation MonitoringRadiotherapy, AdjuvantProstatic NeoplasmsDose FractionationRisk FactorsLung NeoplasmsRadiotherapy Planning, Computer-AssistedNeoplasm StagingRadiation PneumonitisNeoplasms, Radiation-InducedNeoplasm Recurrence, LocalPrognosisEarly Detection of CancerTreatment OutcomeSurvival AnalysisRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsSurvival RateBrachytherapyRadiometryNeoplasm MetastasisHead and Neck NeoplasmsAntineoplastic AgentsCarcinoma, Squamous CellFollow-Up StudiesDisease-Free SurvivalOvarian NeoplasmsRadiation-Sensitizing AgentsChemotherapy, AdjuvantStomach NeoplasmsRadiosurgeryRadiation Injuries, ExperimentalGamma RaysColonic NeoplasmsAdenocarcinomaPancreatic NeoplasmsBrain NeoplasmsTumor Markers, BiologicalCarcinoma, Non-Small-Cell LungCosmic RadiationNeoplasm InvasivenessRectal NeoplasmsRadiotherapy, Computer-AssistedCell Line, TumorFluorouracilRadiotherapy, Image-GuidedUterine Cervical NeoplasmsCranial IrradiationCarcinomaMice, NudeGene Expression Regulation, NeoplasticCisplatinProspective StudiesParticle AcceleratorsRadiodermatitisColorectal NeoplasmsTime FactorsProstate-Specific AntigenTumor BurdenRadiation-Protective AgentsCancer VaccinesRadiotherapy, High-EnergyOrgans at RiskNeoplasm ProteinsChemoradiotherapyTomography, X-Ray ComputedKaplan-Meier EstimateDisease ProgressionBackground RadiationNeoplasms, Second PrimaryMastectomy, SegmentalSurvivorsMastectomyRiskSEER ProgramMedical OncologyXenograft Model Antitumor AssaysCell SurvivalUrinary Bladder NeoplasmsDrug Resistance, Neoplasm